Skip to nav Skip to content

IDSA Practice Guideline Highlights & Status

Listed below is a summary of 2024, 2025 and 2026 highlights for IDSA guidelines as well as guidelines endorsed by IDSA.

Advertisement

Guideline

Publication Date

Journal
Guidelines Released in 2026
SHEA/SIDP/PIDS/IDSA Guidance for the Knowledge and Skills Required for Antimicrobial Stewardship Leaders 5/2026 Antimicrobial Stewardship & Healthcare Epidemiology
SCCM Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026 3/2026 Pediatric Critical Care Medicine
SCCM Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026 3/2026 Critical Care Medicine
IDSA/PIDS 2026 Guidelines for the Management of Community-Acquired Pneumonia (CAP) in Infants and Children Older Than 3 Months of Age 2/2026 TBA
ACOG 2026 Maternal Immunization Schedule 2/2026 Obstetrics & Gynecology
AAP Recommended Childhood and Adolescent Immunization Schedule: United States 2026 Policy Statement 2/2026 Pediatrics
Guidelines Released in 2025
AASLD/IDSA Practice Guideline Update on Treatment of Chronic Hepatitis B 11/2025 Hepatology
Vaccines for Seasonal Respiratory Viruses in the Immunocompromised 10/2025 TBA
COVID-19 Treatment and Management (Focused Guideline Update: Baricitinib vs. Tocilizumab) 10/2025 Clinical Infectious Diseases
COVID-19 Treatment and Management (Focused Guideline Update: Outpatient Antivirals) 10/2025 Clinical Infectious Diseases
Group A Streptococcal (GAS) Pharyngitis 10/2025 TBA
Complicated Urinary Tract Infections cUTI: Clinical Guidelines for Treatment and Management 7/2025 TBA
COVID-19 Treatment and Management (Focused Guideline Update: Abatacept) 5/2025 Clinical Infectious Diseases
COVID-19 Treatment and Management (Focused Guideline Update: Infliximab) 5/2025 Clinical Infectious Diseases
SHEA/APIC/IDSA/PIDS Multisociety Position Paper: Raising the Bar - Necessary Resources and Structure for Effective Healthcare Facility Infection Prevention and Control Programs 4/2025 Infection Control & Hospital Epidemiology
SHEA Multisociety Guidance for Sterilization and High-Level Disinfection 4/2025 Infection Control & Hospital Epidemiology
Histoplasmosis Guideline Update (Multi-Part Series: Part 1) 3/2025 IDSA & Clinical Infectious Diseases
COVID-19 Treatment and Management (Focused Guideline Update: Vilobelimab) 2/2025 IDSA & Clinical Infectious Diseases
Drug-Susceptible and Drug-Resistant Tuberculosis (Joint with ATS/ERS/CDC) 1/2025 American Journal of Respiratory and Critical Care Medicine
Guidelines Released in 2024
Primary Care Guidance Update (Joint with HIVMA) 10/2024 Clinical Infectious Diseases
COVID:19 Treatment and Management (Focused Guideline Update: Pemivibart) 8/2024 IDSA & Clinical Infectious Diseases
Antimicrobial Resistance Update 7/2024 IDSA & Clinical Infectious Diseases
Intra-abdominal Infections (Multi-Part Series: Part 1) 6/2024 IDSA & Clinical Infectious Diseases
Lab ID Guidance (Joint with ASM) 3/2024 Clinical Infectious Diseases

Updates to COVID-19 guidelines:

Diagnostics: Serology

 2/2024

IDSA & Clinical Infectious Diseases

 

Listed below is a summary of IDSA guidelines in development. 

Guideline

Publication Date (Estimated)

Journal
Antimicrobial Prophylaxis in Surgery (Joint with ASHP/SHEA/SIS) 2026, Q4 American Journal of Health-System Pharmacy
Aspergillosis (Multi-Part Series) 2026, Q3 (Part 1) Clinical Infectious Diseases
Community-Acquired Pneumonia in Children (Joint with PIDS) 2026, Q2 Clinical Infectious Diseases
Diagnosis and Management of HAP/VAP (Joint with ATS) 2026, Q4 Clinical Infectious Diseases
HCV (Joint with AASLD) Ongoing Hepatology
Immunomodulators 2026, Q3 Clinical Infectious Diseases
Staphylococcus aureus Bacteremia (Joint with ESCMID) (Multi-Part Series) 2026, Q4 (Part 1) Clinical Infectious Diseases
Strep Pharyngitis (Multi-Part Series) 2026, Q4 (Part 2) Clinical Infectious Diseases
Treatment of Uncomplicated Urinary Tract Infections (Multi-Part Series) 2026, Q4 (Part 2) Clinical Infectious Diseases

Updates to COVID-19 Guidelines:

Treatment and Management

 Ongoing IDSA & Clinical Infectious Diseases